|
|
 |
|
Viewing report
|
|
|
|
Development of New Antibiotics Hits a Road Block
GlobalData, Sep 2011, Pages: 6
Development of New Antibiotics Hits a Road Block
Summary
GlobalData, the industry analysis specialist, has released its new viewpoint, “Development of New Antibiotics Hits a Road Block”. The viewpoint is an essential source of information and analysis which provides the reasons for the downturn in the development of new antibiotics. The viewpoint provides insights on the delay in approvals and regulatory hurdles in the approval of antibiotics over the years
Scope
- The report provides information on FDA approval of new antibiotics and identifies the diminishing numbers of antibiotics.
- It also provides the comparative analysis of FDA drug approvals by therapeutic category.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving FDA drug approvals of antibiotics by therapeutic category
|
|
|
|
